Healthy Subjects
Conditions
Brief summary
A Study to determine if a high-fat meal has an effect on the pharmacokinetics of bosutinib.
Interventions
DRUGBosutinib
Bosutinib fasting
Sponsors
Wyeth is now a wholly owned subsidiary of Pfizer
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes
Inclusion criteria
* Healthy men, age 18-50; * Healthy women of nonchildbearing potential, age 18-50.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pharmacokinetics (plasma concentrations) | 4 weeks |
Countries
United States
Outcome results
None listed